Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
27.70
-0.10 (-0.36%)
At close: Mar 20, 2026, 4:00 PM EDT
28.40
+0.70 (2.51%)
After-hours: Mar 20, 2026, 7:44 PM EDT
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $19.82 billion as of March 20, 2026. Its market cap has increased by 162.11% in one year.
Market Cap
19.82B
Enterprise Value
15.40B
1-Year Change
162.11%
Ranking
Category
Stock Price
$27.70
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $19.82B, an increase of 3,616.87%. That is a compound annual growth rate of 98.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 19.82B | 31.36% |
| Dec 31, 2025 | 15.09B | 75.25% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 31.34B |
| Insmed | 30.94B |
| BioNTech SE | 22.20B |
| Moderna | 20.62B |
| Revolution Medicines | 19.70B |
| Royalty Pharma | 19.59B |
| Incyte | 18.45B |
| Genmab | 15.59B |